ECB Warns of Financial Risks from U.S. Stablecoin Surge

According to analysts, the European Union could face a regulatory disadvantage compared to the U.S., potentially destabilizing its financial system due to capital outflows.

The U.S. Dollar Might Be Pressured by Stablecoin Issuance.

The European Central Bank (ECB) has raised a red flag over the potential boost the crypto industry could receive under a second Donald Trump administration. Its main concern centers on a possible influx of dollar-backed stablecoins into EU markets, which it warns could destabilize the bloc’s financial system.

As reported by Politico, the ECB has called for a review of the Markets in Crypto-Assets (MiCA) regulatory framework—despite it having taken effect only a few months ago. The fear is that advancing U.S. legislation, such as the STABLE Act and the GENIUS Act—both backed by Trump—could lead to a surge in stablecoin issuance. If these assets circulate widely in Europe, they could trigger capital flight toward U.S.-denominated instruments.

The ECB warns that this expansion of dollar-backed digital assets could undermine the EU’s financial sovereignty and create liquidity risks for local banks if European issuers face large redemption demands from both domestic and foreign holders. In a worst-case scenario, this could lead to a financial run.

Europe Faces Renewed Criticism Over Its Crypto Regulations

Despite the ECB’s concerns, there is no consensus within the EU on the need to revise existing regulations. The European Commission dismissed the ECB’s warnings as overstated. “The Commission was quite clear that it holds a different view on the matter,” said one EU diplomat quoted by Politico, adding that there isn’t enough support among member states to fast-track any MiCA revision.

Currently, the global stablecoin market is valued at $234 billion, according to CoinMarketCap. However, no stablecoin issued under EU regulations has gained significant global traction due to MiCA-imposed restrictions. Mikko Ohtamaa, CEO of Trading Strategy, remarked on social media that the EU “lost its edge” after being the first to regulate the industry, effectively leaving the door open for the U.S. to lead.

Tether, the issuer of the world’s most widely used stablecoin (USDT), has also criticized the European framework. CEO Paolo Ardoino warned that the MiCA requirement to hold at least 60% of reserves in EU bank accounts could, instead of reducing risk, create systemic stress for both stablecoin issuers and the banking sector.

Bitcoin Rebounds to Over $90,000, Highest Level in More Than a Month

Cryptocurrencies are rising this Tuesday, supported by a rebound on Wall Street. Bitcoin has surged past $90,000, gaining 2.7% in the last 24 hours, while most altcoins are also in the green—with gains of up to 6.7%—led by SUI, Dogecoin (+5.4%), and Solana (+3.3%).

Despite Trump’s Trade Policies, BTC is Acting like a Hedge.

On Wall Street, stocks are climbing as traders attempt to recover from Monday’s downturn, which was triggered by fresh criticism from former President Trump directed at Fed Chair Jerome Powell, shaking investor confidence. The Dow Jones Industrial Average is up 573 points (1.5%), the S&P 500 is rising 1.5%, and the Nasdaq Composite is up 1.8%.

[[BTC/USD-graph]]

In this volatile environment, technical analysis is taking center stage again. Renowned analyst Doctor Profit had predicted Bitcoin’s recent behavior with surprising accuracy. In a post dated March 21, he forecasted a rebound from the 50-week exponential moving average (EMA 50)—which he calls the “Golden Line”—around $76,000, followed by a rally toward the $87,000–$88,000 range. That scenario has unfolded almost exactly throughout April.

His forecast partly relied on the relationship between Bitcoin and the M2 money supply—an indicator Doctor Profit believes is underestimated by the market. In his view, the rally that began in September 2024 had already priced in the liquidity expansion seen since February, contradicting the prevailing investor narrative.


What the Market Is Watching Now

Attention is now turning to the next phase of Bitcoin’s movement: a potential correction into the $70,000–$74,000 range. According to the analyst, this zone will be a key inflection point. If Bitcoin briefly dips into that range but closes above the Golden Line, it would confirm a bullish reversal, encouraging the accumulation of long positions. Conversely, a sustained close below that support level could trigger a deeper drop—potentially as low as $50,000 in an extreme “Black Swan” scenario, as described by the analyst.

Despite this short-term bearish warning, Doctor Profit remains optimistic about the second half of 2025. He believes that after the correction expected in April or early May, the market could resume its upward trend, aiming for new all-time highs in the $120,000–$140,000 range between May and June.

For now, with Bitcoin trading at $87,526 and climbing more than 3% daily, all eyes are on whether the price can close the week above $100,000. Such a move would completely invalidate the current bearish thesis and potentially mark the beginning of a new bullish cycle.

MicroStrategy Stock (MSTR) Price Soars 9% as BTC Breaks Above $90K

MicroStrategy MSTR shares are rallying sharply as surging Bitcoin prices reignite investor appetite for crypto-heavy tech stocks.

Continue reading “MicroStrategy Stock (MSTR) Price Soars 9% as BTC Breaks Above $90K”

Bitcoin benefits From U.S dollar Crash

The pioneer cryptocurrency asset peaked at $88,500  as the dollar index maintained a 3-year low. BTC held firm despite a marginal drop in the global cryptocurrency market capitalization to $2.75 trillion.

 

The Crypto Fear and Greed Index showed a level of 31, indicating overwhelming fear that has remained entrenched since February.

The recent surge in bitcoin was driven by institutional demand, as seen by Monday’s $381.40 million inflow into US spot Exchange Traded Funds (ETFs). Microstrategy (MSTR) purchased 6,556 Bitcoins for $556 million.

SoSoValue data highlighted Monday’s net inflow of $381.40 million into the US spot Bitcoin ETF was the largest daily inflow since January 30. Despite being much less than the inflows seen in early November, these inflows are good for Bitcoin because they show high institutional demand.

The US Dollar Index, which measures the US Dollar (USD) strength against six major currencies, is stagnant near a three-year low during the week on Tuesday.

The markets were taken aback when the US Dollar dropped in value during the Asian trading session and when European and US markets operated with a skeleton crew due to the Easter Monday bank holiday.

United States President Donald Trump has shifted his attention to the Fed and targeted Jerome Powell, calling him “a major loser” for not cutting interest rates and exploring ways to dismiss the Chairman, adding more downward pressure on the Greenback.

Chairman Trump intensifies his onslaught against the Fed with glaring insults, and the threat of an economic cloudy day has sparked economic snowstorm déjà vu.

DOJ Lawsuit: Google warns Split gives China advantage

Alphabet claims the US needs Google in its complete form to compete with its primary competitor, China, while simultaneously defending national security.

 

This trial follows the judge’s decision regarding the remedies for Google, which has established a monopoly in the internet search market, the fundamental market for every business in the technology industry.

Google, like Microsoft, faced one of the most significant antitrust cases in the technology sector over twenty years ago.

The US Government has proposed unbundling Google’s Chrome browser, which means the company must open its search data to competitors. Google is eager to respond to this suggestion, published on its blog, that it is not in the best national interest for the US, and even less so for the global landscape, as the emphasis on competition for world domination in artificial intelligence intensifies.

In the first paragraph of its post, Google referred to China’s DeepSeek as a developing AI contender. The suggestion by the Department of Justice would, Mulholland claims, “restrict the ways we can create AI, and have a government-sanctioned board control the governance of our services.”

He adds, “That would stifle American innovation at a crucible moment. We’re precipitously competing internationally with China for the successor of technological leadership, and Google is leading the battalion of American entities executing scientific and technological innovation.”

High Sell-Offs in U.S Treasuries Scare Market

The 10-year US Treasury yield increased as stalled global trade developments weighed on investor sentiment.

The benchmark yield on the 10-year Treasury was 4.4263 percent, two basis points higher. The 2-year Treasury yield rose by more than five basis points to 3.8064 percent.

Investor confidence remained low despite the stalling of international trade negotiations. Beijing warned other nations against entering into agreements with the US that might be detrimental to China’s interests, seemingly escalating tensions between the two largest economies in the world.

President Donald Trump’s pressure on US Federal Reserve Chairman Jerome Powell to lower rates undermined the trust in US assets.

A  steep selloff in the US Treasury market raised questions about who is selling them. According to preliminary information provided by Japan’s finance ministry and analyzed by Moody’s Analytics, Japanese investors may have sold some foreign bonds, most likely Treasuries, not in sufficient quantities to account for the yield spike, the analytics company wrote in a note.

Moody’s Analytics’ head of Japan and frontier markets economics, Stefan Angrick, stated that between March 30 and April 12, “weekly statistics on international securities flows show major Japanese investors were net sellers of foreign long-term bonds, most likely US Treasuries.”

Roche plan investing $50 Billion in U.S

Swiss pharmaceutical giant Roche announced on Tuesday that it would invest $50 billion in the US over the next five years. This comes amid worries about the potential effects of new White House tariffs on pharmaceutical products from overseas.

According to Roche, the investment will support new manufacturing capabilities in the United States and create over 12,000 jobs, 1,000 of which will be with the company. Roche has 25,000 employees in the world’s largest economy.

In addition to strengthening and expanding its manufacturing facilities in Indiana, Pennsylvania, Massachusetts, and California, the pharmaceutical behemoth will invest in establishing new, cutting-edge research and development (R&D) sites.

AI research will be conducted at a new R&D facility in Massachusetts, which will also serve as a center for studies on treatments for metabolism, kidney disease, and cardiovascular disease.

The funding package will also be used to construct a new manufacturing facility in an undisclosed location to support Roche’s “expanding portfolio of next-generation weight loss medicines,

Roche stated that it would export more medications from the US than it imports after the manufacturing capacity investments are completed.

Pharmaceutical companies have been rushing to increase their US presence, with President Donald Trump threatening to remove the pharmaceutical industry’s exemption from import duties.

 

Oracle Stock Under Pressure: Can ORLC Hold $120 or Is Another Breakdown Ahead?

Oracle stock continues to struggle amid earnings disappointment, trade war tensions, and failed technical rebounds. Will the $120 support zone hold, or is more downside in store?

Continue reading “Oracle Stock Under Pressure: Can ORLC Hold $120 or Is Another Breakdown Ahead?”

Ripple: XRP classified a ‘crypto security’ in lawsuits against Coinbase

XRP, the cryptocurrency associated with Ripple, sustained considerable damage when Oregon’s AG Dan Rayfield included it with several other tokens in a class action lawsuit against Coinbase on the list of unregistered securities.

 

Coinbase, in its defense statement, claimed that the AG was trying to bring back some form of regulation through enforcement, which begs the question of why Rayfield, who chased reality, let go of his reasoning and slapped such a lawsuit that is essentially devoid of merit.

The designation XRP as ‘crypto security’ is a contradiction, considering the token is said to have some regulatory clarity. A federal judge ruled in 2023 that XRP is not a security when sold to retail investors on public exchanges and must be accepted.

This was after the SEC dropped their appeal, along with former Chair Gary Gensler, who stepped down earlier this year.

Meanwhile, XRP futures trading by Coinbase Derivatives and an increase in open interest are two factors that might be driving the token’s bullish momentum.

Although the cryptocurrency market experienced improvements and technical indicators are signaling buy opportunities, a loss of support at $2 could accelerate losses to the 200-day EMA at $1.95.

Coinbase Derivatives, a division of the Coinbase cryptocurrency exchange, may begin trading XRP futures contracts on Monday. Coinbase declared Coinbase Derivatives had submitted a request to “self-certify” XRP futures to the Commodities Futures Trading Commission (CFTC) on April 4.

If approved, this development would facilitate institutional adoption of XRP, providing investors access to a regulated instrument for one of the most liquid digital assets in the market.

 

Solana Price Prediction: Can SOL Hit $146 on Ark ETF Hype?

Solana (SOL) is back in the institutional spotlight. Cathie Wood’s Ark Invest has added the 3iQ Solana Staking ETF (SOLQ) to its ARKW and ARKF ETFs, showing more confidence in the blockchain’s long term value and the emerging staking economy.

Unlike passive exposure to price action, SOLQ taps into Solana’s yield generating mechanics—an attractive proposition for forward thinking investors.

This is a big moment. Solana is trading at $138, with a $72.3 billion market cap and $3.9 billion in daily volume. It’s the 6th largest cryptocurrency by market cap and holding strong against the broader market.

By adding SOLQ to both ARKW and ARKF, Ark is bringing Solana into traditional finance—SOL is moving beyond early adopter speculation and into mainstream portfolios.

Solana Technical Outlook: Breakout in Focus

Technically [[SOL/USD]] is coiling below $140, inside a rising price channel that’s held since early April. Bulls have defended $138.39 multiple times and the 50 period EMA at $137 is a solid floor.

A breakout above $140 could lead to:

  • $143.17 – previous high and near term resistance
  • $146.39 – top of the channel and major breakout level

 

Solana Holds $138—Eyes Rebound Toward $143 and $146
Solana Holds $138—Eyes Rebound Toward $143 and $146

If $138 fails, downside risk is to $134.74. But the long term trend is still bullish as long as SOL is above the 200 EMA at $130.31.

Key Levels:

  • Support: $138.39, $134.74
  • Resistance: $140.00, $143.17, $146.39
  • Indicators: Bullish EMA trend, MACD turning positive but not yet decisive

Why Solana’s Staking Ecosystem Matters

More than just a chart pattern, Solana’s fundamental story is getting stronger. Its proof of stake infrastructure is actually generating yield—a feature that’s increasingly attractive to institutional investors looking for blockchain utility beyond speculation.

That’s where SOLQ shines. As a staking ETF, it gives exposure not just to SOL’s price but to its core value proposition: earning yield through network participation. It’s a model that’s similar to Ethereum’s shift to staking but with faster throughput and lower costs—a narrative Ark Invest is betting on.

With Ark’s backing and the technicals in place, Solana could be looking at more than just a move to $146. If the broader market improves and ETF momentum holds, all time highs could be next.